CIK 0001802768
- Large accelerated filer
Royalty Pharma plc
Sign in to watch- Ticker
- RPRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +1 212-883-0200
- Business address
- 110 EAST 59TH STREET, NEW YORK, NY, 10022
- 4 Grant or award Director acquired 9,293 shares (grant or award)
- 4 Grant or award Director acquired 9,293 shares (grant or award)
- 4 Grant or award Director acquired 9,293 shares (grant or award)
- 4 Grant or award Director acquired 9,293 shares (grant or award)
- 4 Grant or award Director acquired 9,293 shares (grant or award)
- 4 Grant or award Director acquired 9,293 shares (grant or award)
- 4 Conversion EVP & Vice Chairman acquired 300,000 shares (conversion)
- 4 Grant or award Director acquired 1,240 shares (grant or award)
- 4 Grant or award Director acquired 1,240 shares (grant or award)
- 4 Conversion Director acquired 300,000 shares (conversion)
- 4 Planned sale Director sold 470,000 shares at an average $28.13 ($13,222,862)
- 4 Open-market sale 10% owner sold 65,803 shares at $28.04 ($1,845,406)
- 4 Grant or award Director acquired 1,353 shares (grant or award)
- 4 Grant or award Director acquired 1,353 shares (grant or award)
- 4 Open-market sale 10% owner sold 251,592 shares at an average $28.17 ($7,087,688)
- 4 Open-market sale 10% owner sold 10,229 shares at $28.01 ($286,499)
- 4 Open-market sale 10% owner sold 672,376 shares at an average $28.93 ($19,450,288)
- 4 Gift CEO, Chairman of the Board gave 292,190.49 shares (gift)
- 4 Conversion EVP, Investments & CLO acquired 150,000 shares (conversion)
- 4 Conversion Director acquired 475,590 shares (conversion)
Page 7 of 18 · 342 filings